Patents-Review.com
ClassID:

20487 ⎘

A61K31/616 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid

Recent Application in this class:
#301
20200061085
2020-02-27

COMPOSITION FOR TREATMENT, INHIBITION AND ATTENUATION OF MELANOMA VIRUS AND PREVENTION OF SKIN CANCERS

 #302
20200046832
2020-02-13

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND LENALIDOMIDE

 #303
20200046673
2020-02-13

Method of treating patients with a factor Xa inhibitor, aspirin, and verapamil

 #304
20200046644
2020-02-13

Combination Tablet With Chewable Outer Layer

 #305
20200016123
2020-01-16

Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions

 #306
20200009257
2020-01-09

Liquid topical pharmaceutical nano-emulsion formulations

 #307
20200000716
2020-01-02

Multicomponent gummy compositions with hard core

 #308
20190391131
2019-12-26

BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE

 #309
20190388354
2019-12-26

IMPROVED COMPOSITIONS AND METHODS FOR REDUCING OVERDOSE

 #310
20190374487
2019-12-12

Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent

 #311
20190358190
2019-11-28

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #312
20190350946
2019-11-21

Medical device for the treatment of HPV cutaneous infections

 #313
20190350888
2019-11-21

COMPOSITION FOR THE TREATMENT OF VEISALGIA

 #314
20190336448
2019-11-07

Dry powder compositions with magnesium stearate

 #315
20190336332
2019-11-07

TREATMENT OF SPINAL MUSCULAR ATROPHY BY INDUCING HEAT SHOCK RESPONSE

 #316
20190321441
2019-10-24

NOVEL COMBINATION AND USE

 #317
20190321296
2019-10-24

Inhaled aspirin and magnesium to treat inflammation

 #318
20190314303
2019-10-17

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

 #319
20190305084
2019-10-03

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #320
20190298995
2019-10-03

Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes

 #321
20190290663
2019-09-26

One-stop Surgical Method of Coronary Intervention Therapy Combined with Endovascular Aortic Repair

 #322
20190285643
2019-09-19

Systems and methods to identify and treat subjects at risk for obstetrical complications

 #323
20190282499
2019-09-19

Methods and compositions to treat enteropathic arthritis

 #324
20190275153
2019-09-12

Compositions and methods for reducing overdose

 #325
20190274980
2019-09-12

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

 #326
20190262379
2019-08-29

Treatments of non-alcoholic steatohepatitis (NASH)

 #327
20190262264
2019-08-29

Devices and methods for treating ear pain

 #328
20190247304
2019-08-15

Treating inflammation with inhaled aspirin

 #329
20190240231
2019-08-08

Reducing the risk of cardiovascular events

 #330
20190224427
2019-07-25

DRY POWDER INHALER AND METHODS OF USE

 #331
20190224131
2019-07-25

DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF

 #332
20190216720
2019-07-18

Methods and compositions for treating migraine and conditions associated with pain

 #333
20190211103
2019-07-11

Pharmaceutical combination and method for regulation of tumor microenvironment and immunotherapy

 #334
20190201430
2019-07-04

TREATING OCULAR NEOVASCULARIZATION

 #335
20190201357
2019-07-04

Glutarate compounds for treating ischemia-reperfusion injuries

 #336
20190192670
2019-06-27

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof

 #337
20190183795
2019-06-20

Solid solution compositions and use in chronic inflammation

 #338
20190169130
2019-06-06

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

 #339
20190142760
2019-05-16

Particle-based multi-layer therapeutic delivery device and method

 #340
20190134066
2019-05-09

Treatment of moderate to severe influenza

 #341
20190134065
2019-05-09

Compounds for prenatal treatment comprising a natal vitamin and aspirin and methods for making and using the same

 #342
20190117598
2019-04-25

METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTIPLATELET AGENT

 #343
20190113518
2019-04-18

Predictive markers for polyamine inhibitor cancer therapies

 #344
20190105283
2019-04-11

Delivery systems

 #345
20190105267
2019-04-11

Dry powder formulations and methods of use

 #346
20190099412
2019-04-04

Analgesic compositions

 #347
20190092731
2019-03-28

Multifunctional aminoquinoline therapeutic agent

 #348
20190091243
2019-03-28

FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA

 #349
20190091185
2019-03-28

Solid solution compositions and use in chronic inflammation

 #350
20190091155
2019-03-28

COMBINATION TABLET WITH CHEWABLE OUTER LAYER

 #351
20190083624
2019-03-21

Solid solution compositions and use in severe pain

 #352
20190083623
2019-03-21

Solid solution compositions and use in cardiovascular disease

 #353
20190083394
2019-03-21

Dry powder formulations for inhalation

 #354
20190070201
2019-03-07

FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA

 #355
20190070137
2019-03-07

Solid solution compositions and use in chronic inflammation

 #356
20190070118
2019-03-07

Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

 #357
20190070099
2019-03-07

PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

 #358
20190048050
2019-02-14

Peptide-based methods for treating neurological injury

 #359
20190046510
2019-02-14

NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR

 #360
20190038642
2019-02-07

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

 #361
20190038568
2019-02-07

Delivery systems

 #362
20190035891
2019-01-31

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #363
20190035890
2019-01-31

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #364
20190030008
2019-01-31

CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES

 #365
20190029980
2019-01-31

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #366
20190022042
2019-01-24

Extended, delayed and immediate release formulation method of manufacturing and use thereof

 #367
20190015360
2019-01-17

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation

 #368
20190008851
2019-01-10

Compositions and kits useful for treatment of respiratory illness

 #369
20190008811
2019-01-10

Solid solution compositions and use in chronic inflammation

 #370
20190000785
2019-01-03

Solid solution compositions and use in chronic inflammation

 #371
20180360924
2018-12-20

TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION

 #372
20180360811
2018-12-20

Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections

 #373
20180360781
2018-12-20

Compositions and methods useful for treatment of respiratory illness

 #374
20180360780
2018-12-20

Compositions And Methods Useful For Treatment Of Respiratory Illness

 #375
20180360779
2018-12-20

Compositions And Methods Useful For Treatment Of Respiratory Illness

 #376
20180360778
2018-12-20

Compositions and methods useful for treatment of respiratory illness

 #377
20180353429
2018-12-13

PRODUCT COMPRISING HYDROLIZED COLLAGEN AND AT LEAST ONE AMORPHOUS MICRONIZED DRUG, PROCESS FOR THE PREPARATION THEREOF AND RELATED USES IN MEDICAL FIELD

 #378
20180344802
2018-12-06

Pharmaceutical formulation for bedwetting and method of use thereof

 #379
20180344674
2018-12-06

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #380
20180344673
2018-12-06

PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF

 #381
20180343874
2018-12-06

Honey based biocide composition

 #382
20180339056
2018-11-29

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof

 #383
20180339016
2018-11-29

Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof

 #384
20180338937
2018-11-29

PHARMACEUTICAL PREPARATIONS

 #385
20180338933
2018-11-29

Compositions and methods useful for treatment of respiratory illness

 #386
20180325850
2018-11-15

VALPROIC ACID FOR TREATMENT OF MYOCARDIAL ISCHEMIA

 #387
20180325846
2018-11-15

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #388
20180318398
2018-11-08

METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN

 #389
20180318355
2018-11-08

METHODS AND COMPOSITIONS FOR IMPROVED TISSUE REGENERATION BY SUPPRESION OF INTERFERIN-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA

 #390
20180311186
2018-11-01

PHARMACEUTICAL FORMULATION FOR BEDWETTING AND METHOD OF USE THEREOF

 #391
20180303801
2018-10-25

UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND NIZATIDINE

 #392
20180296676
2018-10-18

PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF

 #393
20180296489
2018-10-18

Capsule with internal diaphragm and solid ingredients

 #394
20180289625
2018-10-11

Capsule with volume-adjustable internal diaphragm

 #395
20180271886
2018-09-27

TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

 #396
20180268669
2018-09-20

Emergency Responder Alert System

 #397
20180264014
2018-09-20

Compositions and methods for treating multiple sclerosis

 #398
20180264013
2018-09-20

COMPOSITION AND METHODS FOR TREATING SLEEP DISORDERS

 #399
20180263946
2018-09-20

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #400
20180263917
2018-09-20

SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE

 #401
20180256725
2018-09-13

AQUEOUS DRUG DELIVERY SYSTEM

 #402
20180243321
2018-08-30

Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections

 #403
20180235899
2018-08-23

Particle-based multi-layer therapeutic delivery device and method

 #404
20180233558
2018-08-16

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #405
20180228818
2018-08-16

PHARMACEUTICAL COMPOSITION COMPRISING ASPRIN, METFORMIN, AND SEROTONIN WITH NON-IONIC SURFACTANT

 #406
20180228731
2018-08-16

Polyphenolic polymer to make water-insoluble molecules become water-soluble

 #407
20180221397
2018-08-09

Formulations and compositions for rejuvenation of the body

 #408
20180221273
2018-08-09

Transdermal administration of antioxidant for treatment of pain and inflammation

 #409
20180214460
2018-08-02

Tablet

 #410
20180207180
2018-07-26

Methods for treating and preventing nociceptive pain

 #411
20180200210
2018-07-19

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

 #412
20180185354
2018-07-05

Immediate release abuse-deterrent granulated dosage forms

 #413
20180185319
2018-07-05

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

 #414
20180177805
2018-06-28

Intravitreal Lysine Acetylsalicylate As Treatment For Diabetic Retinopathy

 #415
20180177751
2018-06-28

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation

 #416
20180169077
2018-06-21

Prophylactic and/or therapeutic agent for fibromyalgia

 #417
20180114600
2018-04-26

METHODS AND SYSTEMS FOR DETERMINING RISK OF A PREGNANCY COMPLICATION OCCURRING

 #418
20180078569
2018-03-22

KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID

 #419
20180072652
2018-03-15

Aspirin derivatives and uses thereof

 #420
20180071316
2018-03-15

Compositions and methods for treating dementia

 #421
20180064890
2018-03-08

DRY POWDER INHALER AND METHODS OF USE

 #422
20180055858
2018-03-01

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #423
20180055782
2018-03-01

Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of NSAIDS

 #424
20180050003
2018-02-22

Solid solution compositions and use in chronic inflammation

 #425
20180050002
2018-02-22

Solid solution compositions and use in chronic inflammation

 #426
20180042877
2018-02-15

Solid solution compositions and use in chronic inflammation

 #427
20180036296
2018-02-08

Benzamides and related inhibitors of factor Xa

 #428
20180015142
2018-01-18

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5

 #429
20180015089
2018-01-18

Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction

 #430
20180008540
2018-01-11

Unit aerosol doses for anticoagulation

 #431
20180000784
2018-01-04

PAR4 INHIBITOR THERAPY FOR PATIENTS WITH PAR4 POLYMORPHISM

 #432
20180000750
2018-01-04

ANTIPLATELET AGENT AND USES THEREOF

 #433
20170362182
2017-12-21

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

 #434
20170361078
2017-12-21

ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD

 #435
20170360908
2017-12-21

Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates

 #436
20170360702
2017-12-21

Solid solution compositions and use in chronic inflammation

 #437
20170354667
2017-12-14

Composition and method for treating bipolar disorder

 #438
20170354666
2017-12-14

COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS

 #439
20170348383
2017-12-07

Combination and use

 #440
20170348333
2017-12-07

Dry powder formulations for inhalation

 #441
20170348332
2017-12-07

Salicylate compound composition

 #442
20170340643
2017-11-30

VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY

 #443
20170340600
2017-11-30

Compositions, methods of use, and methods of treatment

 #444
20170335394
2017-11-23

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment

 #445
20170333389
2017-11-23

Method of Ameliorating Clotting Pathologies and Related Materials and Methods

 #446
20170333373
2017-11-23

Glutarate compounds for treating ischemia-reperfusion injuries

 #447
20170326165
2017-11-16

USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION

 #448
20170326119
2017-11-16

NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR

 #449
20170326083
2017-11-16

Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent

 #450
20170319579
2017-11-09

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #451
20170319521
2017-11-09

EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF

 #452
20170319520
2017-11-09

EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF

 #453
20170319479
2017-11-09

ENHANCED STABILITY OF NOVEL LIQUID COMPOSITIONS

 #454
20170312217
2017-11-02

INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF

 #455
20170304815
2017-10-26

Antimicrobial And Biological Active Polymer Composites And Related Methods, Materials and Devices

 #456
20170304238
2017-10-26

Composition for reducing frequency of urination, method of making and use thereof

 #457
20170304190
2017-10-26

PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

 #458
20170296521
2017-10-19

PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THROMBOEMBOLISM AFTER STENT PLACEMENT

 #459
20170296492
2017-10-19

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #460
20170296470
2017-10-19

TWO SPEED MONOLOTHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

 #461
20170273993
2017-09-28

Pharmaceutical composition containing Ginkgolide B and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation thereof and use thereof

 #462
20170266298
2017-09-21

Nebulisation-based method for mixing substances

 #463
20170266208
2017-09-21

Treating and preventing disease with TMA and TMAO lowering agents

 #464
20170266117
2017-09-21

Delayed release drug formulation

 #465
20170258916
2017-09-14

Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive

 #466
20170258912
2017-09-14

Compositions and methods for reducing overdose

 #467
20170252295
2017-09-07

EFFERVESCENT COMPOSITION AND METHOD OF MAKING IT

 #468
20170246194
2017-08-31

Acetaminophen-Containing Analgesic Formulations With Reduced Hepatotoxicity

 #469
20170242021
2017-08-24

Systems and methods to identify and treat subjects at risk for obstetrical complications

 #470
20170231988
2017-08-17

Pharmaceutical composition of rosuvastatin calcium

 #471
20170231919
2017-08-17

DELIVERY SYSTEMS

 #472
20170216335
2017-08-03

METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT

 #473
20170216320
2017-08-03

ASPIRIN FORMULATION FOR INCREASED EFFICACY

 #474
20170209477
2017-07-27

COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM

 #475
20170209467
2017-07-27

Methods for treating solid tumor cancers using a histone deacetylase inhibitor and an IκB kinase inhibitor

 #476
20170196898
2017-07-13

Medicament

 #477
20170165209
2017-06-15

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

 #478
20170157255
2017-06-08

Compositions and methods for reducing overdose

 #479
20170151265
2017-06-01

Pulmonary interstitial pneumonia treatment

 #480
20170143837
2017-05-25

COMPOSITION FOR SKIN PENETRATION, CONTAINING CATIONIC MOLECULE TRANSPORTER AND ANIONIC BIOACTIVE MATERIAL

 #481
20170136128
2017-05-18

Uptake of pharmaceuticals within cyclodextrin-based porous materials

 #482
20170119797
2017-05-04

XYLITOL CONTAINING COMESTIBLE PRODUCT

 #483
20170112859
2017-04-27

METHOD OF TREATMENT USING AN ASSOCIATION OF LOSARTAN AND ACETYLSALICYLIC ACID, AND KIT

 #484
20170112858
2017-04-27

Extended Release Aspirin

 #485
20170112857
2017-04-27

Extended Release Aspirin

 #486
20170105938
2017-04-20

Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

 #487
20170100413
2017-04-13

COMPOSITION FOR REDUCING THE FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #488
20170100351
2017-04-13

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #489
20170087280
2017-03-30

SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT

 #490
20170087090
2017-03-30

PORTABLE POWDER DELIVERY SYSTEM AND METHOD

 #491
20170079964
2017-03-23

COMPOSITION FOR REDUCING THE FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #492
20170079925
2017-03-23

Compositions and methods for reducing overdose

 #493
20170079924
2017-03-23

Compositions and methods for reducing overdose

 #494
20170049851
2017-02-23

Method for Medical Treatment

 #495
20170049729
2017-02-23

Pharmaceutical formulation for reducing frequency of urination and method of use thereof

 #496
20170042926
2017-02-16

Treating ocular neovascularization

 #497
20170042821
2017-02-16

COMBINATION TABLET WITH CHEWABLE OUTER LAYER

 #498
20170042161
2017-02-16

Biocide compositions based on calcium fluoride as well as uses thereof

 #499
20170035786
2017-02-09

METHODS FOR INHIBITING THE DEVELOPMENT, FORMATION AND/OR MATURATION OF BACTERIAL AND FUNGAL BIOFILMS

 #500
20170035734
2017-02-09

PAR4 inhibitor therapy for patients with PAR4 polymorphism

 #501
20170035727
2017-02-09

Treatment or prevention of seborrheic keratosis using artemisinin and derivatives thereof

 #502
20170035698
2017-02-09

Delayed release drug formulation

 #503
20170020945
2017-01-26

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #504
20170020811
2017-01-26

Compositions and methods for combination ingredient delivery

 #505
20170014347
2017-01-19

Dry coated tablet

 #506
20170007703
2017-01-12

COMPOSITION FOR ACCELERATING PENETRATION THROUGH SKIN, PREPARATION FOR TRANSDERMAL ADMINISTRATION, AND SKIN PATCH PREPARATION

 #507
20160375038
2016-12-29

Hormone treatment for age-related hearing loss-presbycusis

 #508
20160367799
2016-12-22

Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes

 #509
20160367479
2016-12-22

Food and beverage compositions infused with lipophilic active agents and methods of use thereof

 #510
20160367413
2016-12-22

Lifesaving kit

 #511
20160331866
2016-11-17

TISSUE REGENERATION MEMBRANE FOR REPAIR AND REGENERATION OF PERIPHERAL NERVE

 #512
20160331747
2016-11-17

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #513
20160331680
2016-11-17

Method of treating ear pain

 #514
20160317511
2016-11-03

Benzamides and related inhibitors of factor XA

 #515
20160317482
2016-11-03

Solid solution compositions and use in chronic inflammation

 #516
20160303138
2016-10-20

Combination Therapy Of Substituted Oxazolidinones

 #517
20160303079
2016-10-20

Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits

 #518
20160303060
2016-10-20

Solid solution compositions and use in chronic inflammation

 #519
20160296474
2016-10-13

Multicomponent gummy compositions with hard core

 #520
20160296470
2016-10-13

Multicomponent gummy compositions with soft core

 #521
20160287627
2016-10-06

METHOD FOR SUPPRESSING ONSET OF GASTRIC ULCER AS ADVERSE EFFECT OF DRUG, ORAL PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ONSET OF GASTRIC ULCER AND METHOD FOR PRODUCING THE SAME

 #522
20160287613
2016-10-06

SALICYLATES FOR USE IN THE TREATMENT OF CANCER

 #523
20160279297
2016-09-29

METHODS FOR INHIBITING STENOSIS, OBSTRUCTION, OR CALCIFICATION OF A STENTED HEART VALVE OR BIOPROSTHESIS

 #524
20160279116
2016-09-29

THERAPEUTIC USES OF NICOTINE

 #525
20160271255
2016-09-22

Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

 #526
20160271053
2016-09-22

Use of stabilized granules containing glyceryl trinitrate for arteriogenesis

 #527
20160263017
2016-09-15

Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure

 #528
20160256383
2016-09-08

Compositions and methods for combination ingredient delivery

 #529
20160250178
2016-09-01

Compositions, methods of use, and methods of treatment

 #530
20160238605
2016-08-18

Myeloperoxidase, a risk indicator for cardiovascular disease

 #531
20160238603
2016-08-18

Myeloperoxidase, a risk indicator for cardiovascular disease

 #532
20160237501
2016-08-18

Biomarkers for diagnosis of transient ischemic attacks

 #533
20160235811
2016-08-18

Compounds and methods for the treatment of vascular disease

 #534
20160220679
2016-08-04

COMPOSITIONS COMPRISING LECITHIN OILS AND NSAIDS FOR PROTECTING THE GASTROINTESTINAL TRACT AND PROVIDING ENHANCED THERAPEUTIC ACTIVITY

 #535
20160220505
2016-08-04

COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION

 #536
20160206624
2016-07-21

Medicament for treatment of Alzheimer's disease

 #537
20160202239
2016-07-14

Blood based biomarkers for diagnosing atherosclerotic coronary artery disease

 #538
20160199327
2016-07-14

Solid solution compositions and use in chronic inflammation

 #539
20160185764
2016-06-30

Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists

 #540
20160184228
2016-06-30

UNILAMELLAR NIOSOMES HAVING HIGH Kow PHARMACOLOGICAL COMPOUNDS SOLVATED THEREIN AND A METHOD FOR THE PREPARATION THEREOF

 #541
20160175385
2016-06-23

Pharmaceutical formulation for bedwetting and method of use thereof

 #542
20160175330
2016-06-23

METHOD OF TREATMENT USING AN ASSOCIATION OF LOSARTAN AND ACETYLSALICYLIC ACID, AND KIT

 #543
20160159779
2016-06-09

Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin

 #544
20160151280
2016-06-02

Enhanced stability of novel liquid compositions

 #545
20160151278
2016-06-02

Method and apparatus for treating ear infections

 #546
20160143922
2016-05-26

ANTI-FLUSH COMPOSITIONS

 #547
20160143848
2016-05-26

Neat liquid pharmaceutical formulations

 #548
20160136286
2016-05-19

DRUG DELIVERY COMPOSITION

 #549
20160136185
2016-05-19

Composition for preventing or treating side effect of steroid in subject comprising acetylsalicylic acid and use thereof

 #550
20160129019
2016-05-12

COMPOSITIONS, METHODS, AND SYSTEMS RELATING TO CONTROLLED CRYSTALLIZATION AND/OR NUCLEATION OF MOLECULAR SPECIES

 #551
20160120924
2016-05-05

Methods and compositions for treating and preventing signs or symptoms of eye disease

 #552
20160120869
2016-05-05

SOLID PHARMACEUTICAL DOSAGE FORM

 #553
20160109448
2016-04-21

Myeloperoxidase, a risk indicator for cardiovascular disease

 #554
20160106763
2016-04-21

Oral formulation for the treatment of cardiovascular diseases

 #555
20160106682
2016-04-21

Enteric Soft Capsules

 #556
20160101089
2016-04-14

Pharmaceutical salts and polymorphs of a factor Xa inhibitor

 #557
20160101073
2016-04-14

Composition for reducing frequency of urination, method of making and use thereof

 #558
20160089387
2016-03-31

Treating and preventing disease with TMA and TMAO lowering agents

 #559
20160089386
2016-03-31

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

 #560
20160089338
2016-03-31

Orally disintegrable tablet

 #561
20160088864
2016-03-31

Liquid or semi-liquid pharmaceutical, dietary or food composition free of bitterness containing an arginine salt

 #562
20160058776
2016-03-03

Active agents and their oligomers and polymers

 #563
20160051569
2016-02-25

Methods for Inhibiting the Development, Formation and/or Maturation of Bacterial and Fungal Biofilms

 #564
20160045450
2016-02-18

Pharmaceutical formulation for use in the treatment and/or prevention of restenosis

 #565
20160039591
2016-02-11

PACKAGING SYSTEMS, DEVICES, METHODS, AND COMPOSITION INCLUDING CANNABINOID UNIT DOSE FORMS

 #566
20160030354
2016-02-04

COMBINATION TABLET WITH CHEWABLE OUTER LAYER

 #567
20160022706
2016-01-28

Treatment of lymphangioleiomyomatosis

 #568
20160022705
2016-01-28

Dry powder formulations for inhalation

 #569
20160022615
2016-01-28

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

 #570
20160022575
2016-01-28

SYSTEM FOR ADMINISTRATION OF CARDIAC PROTECTIVE THERAPY

 #571
20160015662
2016-01-21

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

 #572
20160015660
2016-01-21

Composition for reducing the frequency of urination, method of making and use thereof

 #573
20160015633
2016-01-21

Xylitol containing comestible product

 #574
20160000715
2016-01-07

Combinations of Oral Medicaments Bonded by a Wrapping

 #575
20150374839
2015-12-31

NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES

 #576
20150374835
2015-12-31

LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS

 #577
20150374651
2015-12-31

Extended, delayed and immediate release formulation method of manufacturing and use thereof

 #578
20150366817
2015-12-24

Delayed-release formulations, methods of making and use thereof

 #579
20150359808
2015-12-17

COMPOSITIONS AND METHODS FOR REDUCING HEPATOTOXICITY ASSOCIATED WITH DRUG ADMINISTRATION

 #580
20150353986
2015-12-10

METHODS FOR TREATMENT OF CORONARY HEART DISEASE EVENTS BASED ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITY

 #581
20150352130
2015-12-10

Extended-release formulation for reducing the frequency of urination and method of use thereof

 #582
20150352129
2015-12-10

ASPIRIN FORMULATION FOR INCREASED EFFICACY

 #583
20150342989
2015-12-03

COMPOSITIONS COMPRISING NON STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF

 #584
20150342880
2015-12-03

Solid solution compositions and use in chronic inflammation

 #585
20150328162
2015-11-19

PHARMACEUTICAL PREPARATIONS

 #586
20150320772
2015-11-12

USE OF ACETYLSALICYLIC ACID TO PREVENT AND/OR TREAT DIABETIC WOUNDS

 #587
20150314004
2015-11-05

FREEZE-DRIED EXCIPIENT AND PREPARATION METHOD THEREOF

 #588
20150313916
2015-11-05

Inflammatory disease model and method of treatment

 #589
20150306132
2015-10-29

Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA

 #590
20150301060
2015-10-22

Predictive markers for polyamine inhibitor cancer therapies

 #591
20150297846
2015-10-22

Intranasal medication delivery device and method of use thereof

 #592
20150297617
2015-10-22

Intranasal medication delivery device and method of use thereof

 #593
20150292023
2015-10-15

Materials and Methods Related to NSAID Chemoprevention in Colorectal Cancer

 #594
20150284799
2015-10-08

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT

 #595
20150272912
2015-10-01

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

 #596
20150272896
2015-10-01

Compostions and methods for enhancing the topical application of an acidic benefit agent

 #597
20150272869
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof

 #598
20150272868
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof

 #599
20150272867
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof

 #600
20150272866
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof